BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

eyeonics, Inc.' Quarterly Sales Increase 127%


10/24/2007 7:03:18 AM

ALISO VIEJO, Calif., Oct. 24 /PRNewswire/ -- eyeonics, inc.(TM), the developer of the crystalens(R), the first and only FDA approved accommodating intraocular lens, announced today that revenues for the third quarter ended September 30, 2007 totaled $10.0 million, an increase of 127 percent over the prior year's third quarter revenues of $4.4 million. The crystalens has now been implanted in more than 85,000 eyes worldwide. For the nine months ended September 30, 2007 revenues totaled $23.6 million, an increase of 85 percent over the prior year's nine month revenues of $12.8 million.

About crystalens(R)

The crystalens was approved by the FDA in November 2003. During clinical trials, all of the patients who received the crystalens greatly reduced their need for corrective lenses or eyeglasses. The patented crystalens technology is designed to allow the lens to move in the eye in a manner similar to the natural human lens. By using the eye's muscle to move the lens backwards and forwards naturally, patients can focus through a broad range of vision including near, intermediate and far distances. All other approved intraocular lenses are designed to remain fixed in the eye. For more information about the crystalens go to http://www.crystalens.com.

About eyeonics, inc. (TM)

eyeonics, inc. is a privately held medical device company headquartered in Aliso Viejo, CA., founded in 1998. For more information about eyeonics, inc., go to http://www.eyeonics.com, "about us".

CONTACT: Steven J. Naber, Chief Financial Officer of eyeonics, inc.,
+1-949-389-1783; or media, Steve DiMattia of EVC Group, Inc.,
+1-646-201-5445, for eyeonics, inc.

Web site: http://www.eyeonics.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES